Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Eight-Week, Double-Blind Placebo Controlled, Multicenter Study Evaluating the Efficacy, Safety, Tolerability of a Fixed Dose of SR58611A (350 mg q12) in Elderly Patients With Major Depressive Disorder (MDD)

NCT00319709 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00319709
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00319709 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Eight-Week, Double-Blind Placebo Controlled, Multicenter Study Evaluating the Efficacy, Safety, Tolerability of a Fixed Dose of SR58611A (350 mg q12) in Elderly Patients With Major Depressive Disorder (MDD)
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
April 30, 2006
Completion date
August 31, 2007
Enrollment
288 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

depressive disorder